AR and prostate carcinoma: In this context, many studies have focused on the molecular basis of prostate cancer and highlighted several alterations in well-characterized cancer pathways, the androgen/androgen receptor (AR) signaling, gene fusions or mutations directly related to gene expression, and chromatin regulation.